Is (99m)Tc-MIBI scintigraphy a predictor of response to pre-operative neoadjuvant chemotherapy in Osteosarcoma?

about

Is (99m)Tc-MIBI scintigraphy a predictor of response to pre-operative neoadjuvant chemotherapy in Osteosarcoma?

Item

http://www.wikidata.org/entity/Q39607661

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Is (99m)Tc-MIBI scintigraphy a ...... chemotherapy in Osteosarcoma?

@en

@nl

type

Item

label

Is (99m)Tc-MIBI scintigraphy a ...... chemotherapy in Osteosarcoma?

@en

@nl

prefLabel

Is (99m)Tc-MIBI scintigraphy a ...... chemotherapy in Osteosarcoma?

@en

@nl

P1476

Is (99m)Tc-MIBI scintigraphy a ...... chemotherapy in Osteosarcoma?

@en

P2093

Alireza Hootkani

http://www.w3.org/2001/XMLSchema#string

Alireza Khooei

http://www.w3.org/2001/XMLSchema#string

Gholamhosein Novferesti

http://www.w3.org/2001/XMLSchema#string

Mahdi Farzadnia

http://www.w3.org/2001/XMLSchema#string

Mohammad Gharehdaghi

http://www.w3.org/2001/XMLSchema#string

Vahid Reza Dabbagh Kakhki

http://www.w3.org/2001/XMLSchema#string

P2860

Proteins expressed in osteosarcoma and serum levels as prognostic factors.

Functional imaging of multidrug resistance in an orthotopic model of osteosarcoma using 99mTc-sestamibi.

To use MIBI or not to use MIBI? That is the question when assessing tumour cells.

99Tcm-sestamibi as an agent for imaging P-glycoprotein-mediated multi-drug resistance: in vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistant variant.

The value of Tc-99m-tetrofosmin scintigraphy in the assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors.

The value of 99mTc-MIBI whole body scintigraphy in active and in remission multiple myeloma.

Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells.

Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy.

99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.

The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response.

P304

22-27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ramin Sadeghi

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27408846

http://www.w3.org/2001/XMLSchema#string

P932

4927047

http://www.w3.org/2001/XMLSchema#string